AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
AstraZeneca(AZN) stock is priced at $180.72, giving the company a market capitalization of 280.27B. It carries a P/E multiple of 27.70 and pays a dividend yield of 1.7%.
On 2026-06-01, AstraZeneca(AZN) stock traded between a low of $179.79 and a high of $184.30. Shares are currently priced at $180.72, which is +0.5% above the low and -1.9% below the high.
AstraZeneca(AZN) shares are trading with a volume of 1.22M, against a daily average of 1.74M.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $137.23.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $137.23.
AZN News
The data, being presented at the 2026 American Society of Clinical Oncology Annual Meeting in Chicago, also showed an encouraging trend toward improved overall...
Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
Positive results from the EMERALD-3 Phase III trial showed AstraZeneca’s (AZN) Imfinzi in combination with Imjudo, lenvatinib and transarterial chemoembolizatio...
Analyst ratings
82%
of 28 ratingsMore AZN News
Goldman Sachs analyst James Quigley maintained a Buy rating on AstraZeneca on May 28 and set a price target of p16,525.00. Unlock trusted, data-backed investin...
Key Points Reduced stake by 140,000 shares; estimated transaction value of $4.11 million based on quarterly average price Quarter-end position value fell by $...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst rating...
Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
The company states: “AstraZeneca’s (AZN) IMFINZI – or durvalumab – in combination with Bacillus Calmette-Guerin – BCG – induction and maintenance therapy has be...
AstraZeneca’s (AZN) Imfinzi in combination with Bacillus Calmette-Guerin induction and maintenance therapy has been approved in the U.S. for the treatment of ad...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.